Introduction
In comparison to normal B lymphocytes, chronic lymphocytic leukemia (CLL) cells show prolonged survival in vivo and therefore accumulate in peripheral blood, bone marrow and lymphoid organs of the patients. 1 There is currently no cure for CLL, and even though standard chemotherapeutic regimens decrease the amount of leukemic cells initially, the majority of patients relapse and thereafter show increased drug resistance. 2 Both, intrinsic defects affecting the regulation of programmed cell death (apoptosis) as well as an altered, survival-stimulating microenvironment are discussed as major pathogenic factors for CLL. 1, 3 For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From
The importance of external survival factors is exemplified by the fact that CLL cells rapidly undergo spontaneous apoptosis under culture conditions that support the growth of human B cell lines. 4 On the other hand, CLL cells can be rescued from apoptosis ex vivo, if cocultured with bone marrow-derived stromal cells, fibroblasts, dendritic cells, or nurse-like cells. [5] [6] [7] [8] [9] These cells provide a variety of survival stimuli for CLL cells, mediated via soluble factors, extracellular matrix components, and signals derived from cell-cell contact. 10 The importance of soluble survival factors was demonstrated by in vitro studies using autologous blood serum or conditioned medium of stromal cells, leading to increased survival of CLL cells in culture. 9, 11 By using recombinant cytokines and blocking antibodies targeting selected cytokines, survival-inducing capacity for CLL cells were identified for INF-α, IL1, IL4, IL6, IL8, CD40L, stromal cell-derived factor-1α (SDF1α), B cell-activating factor of the TNF family (BAFF), and a proliferation-inducing ligand (APRIL). 5, [12] [13] [14] [15] [16] It was shown that some of these factors are not only provided by accessory cells, but are also produced by CLL cells themselves, allowing a paracrine and autocrine activation of a variety of signaling pathways in CLL cells. 15 Of importance are PI3K/Akt, NFκB, MAPK/ERK, WNT, and Notch signaling, which are known to be involved in CLL cell survival in vitro. [17] [18] [19] [20] [21] [22] Recently, the selective expression and function of toll-like receptors (TLRs) in CLL cells have been described and TLR-signaling was shown to protect CLL cells from spontaneous apoptosis in vitro via activation of the transcription factor NFκB. 23 TLRs play a key role in innate immunity in that they recognize structurally conserved molecules derived from microbes. CD14, which is mainly expressed by myeloid cells, acts as a co-receptor for TLR-4
for the detection of bacterial lipopolysaccharide (LPS). 24 In addition to the membrane-bound form, CD14 exists also as a soluble protein, which appears either after shedding of membrane-bound CD14 or is directly secreted from intracellular vesicles. Soluble CD14 is secreted by the liver and by monocytes and is sufficient in low concentrations to confer LPSresponsiveness to cells which otherwise do not express CD14. 25 For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From
In the present study, we analyzed the impact of monocytes and soluble factors produced by these cells on primary CLL cells and could show that CLL cell survival ex vivo is maintained in co-cultures with monocytes. We further identified soluble CD14 as a novel survival factor for CLL cells, which is induced in monocytes by the presence of CLL cells and is present in increased levels in the serum of CLL patients.
Patients, Material and Methods
Primary cells and cell lines. Peripheral blood (PB) and serum samples were obtained from CLL patients (Table 1 ) and healthy donors after informed consent in accordance with the Declaration of Helsinki. All studies involving patient samples were approved by the ethics committee of the German Cancer Research Center. All CLL cases used in this study matched the standard diagnostic criteria for CLL. They were selected for their high content of CD5 +
CD19
+ cells in PB. The majority of patients was previously untreated. Only 7 patients had received treatment, which was in all cases more than a year ago. The data obtained with these samples was carefully evaluated and not divergent in comparison to samples from previously untreated patients, which were used in the same experimental set-up. Peripheral blood monocytes were enriched from blood samples of healthy donors by MACS using CD14-specific MicroBeads. Purities of monocyte preparations were analyzed by flow cytometry using FITC-conjugated mAb with specificity for CD14 (clone M5E2) and were higher than 80%. All cells were maintained in DMEM supplemented with 10% FCS, 4 mM LGlutamine, 4.5 g/l glucose, 100 u/ml penicillin, and 100 µg/ml streptomycin (Complete medium), and were cultured at 37°C in a 10% CO 2 humified incubator. CLL/HS-5 cocultures were established as described.
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Cell viability. Apoptotic cell death was detected by flow cytometry using annexin V-PE and 7-amino-actinomycin (7-AAD) staining. Cells were harvested and resuspended in annexin Vbinding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) containing 10%
annexin V-PE and 10% 7-AAD staining solutions (BD Biosciences). After an incubation time of 15 minutes at 4°C, stained cells were analyzed by flow cytometry, gating on lymphocytes. Calculation of efficiency and relative quantification versus non-regulated housekeeping genes were performed as described previously. 26 In supplementary Analysis of NFκB activity. Detection of NFκB activity was performed by using a sensitive oligo-based chemiluminescent ELISA as described previously. 27 Briefly, protein extracts of and quantified apoptotic cells by annexin V-PE and 7-AAD staining. As shown in Figure 5 , in the presence of 10 µg/ml soluble CD14 survival of CLL cells was significantly increased by 9.6% ± 5.1%, ranging from 2.4% to 17.9% (n=14) compared to control cells in complete medium (p=0.00001). As a positive control, we used SDF1α, which was already described as a survival factor for CLL cells. 5 By analyzing the same CLL samples in the presence of 1 µg/ml recombinant human SDF1α, we observed increased cell survival of 17.2% ± 7.2%, ranging from 6.5% to 31.3% (n=10). Both these survival-inducing effects of CD14 or healthy donors by ELISA. Our data show that CD14 levels are significantly increased in CLL patients compared to healthy individuals (1.31 ± 0.22 µg/ml versus 1.12 ± 0.14 µg/ml; Figure   7 ).
Discussion
The dependence of CLL cells on external survival-inducing stimuli is exemplified by the rapid apoptosis of these otherwise long-lived cells, when removed from their natural microenvironment. Bone marrow-derived stromal cells, e.g. the cell line HS-5, were shown to efficiently provide stimuli for long-term survival of CLL cells and are therefore used in coculture model systems to mimic the in vivo microenvironment for in vitro studies of CLL cells. The importance of soluble factors in CLL cell survival was further demonstrated by studies showing increased survival of CLL cells cultured in HS-5 conditioned medium. 9 The data presented in this manuscript show that culturing unsorted PB-derived CLL cells at cell densities, which allow intercellular contact, prevents spontaneous apoptosis of these cells.
This could be due to survival signals transmitted via interactions of cell surface receptors on CLL cells and other non-malignant leukocytes present in these cultures, or due to higher
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From concentration levels of soluble survival factors secreted into the culture medium compared to cultures with lower cell densities. The pro-survival activity in high cell density cultures was dramatically reduced when CD19-sorted CLL cells of the same patients were used. These data demonstrate the importance of non-malignant leukocytes in survival of CLL cells in vitro.
They further show that CLL cells themselves, if cultured densely, maintain survival in an autocrine fashion. Therefore, we conclude that CLL cell survival is regulated by both autocrine and paracrine soluble factors and/or intercellular interactions, which can be either stromal cell-derived or provided by non-malignant leukocytes. This is in accordance with results shown by Bomstein et al., demonstrating that apoptotic levels of isolated CLL cells in culture can be decreased by cultivating them at high cell density (1 x 10 6 cells/ml). 28 Extensive DNA microarray and cytokine antibody array data using survival-inducing CLL cultures identified a variety of inflammatory cytokines and signaling pathways, which showed up-regulated expression and increased secretion or activation. Since many of those cytokines are known to be specific for monocytes and macrophages, we hypothesized that blood-derived monocytes might be the source of the observed survival-inducing activity. In vitro studies Table 1 ) and 10 healthy controls were analyzed by ELISA. Rel. CD14 expression (norm to hkg) 
